(1)
QSAR Study and Molecular Docking of 23‐Hydroxybetulinic Acid Derivatives As RMGPa and HeLa Cells Inhibitors. Commun. Comput. Chem. 2015, 3 (3), 75-102. https://doi.org/10.4208/cicc.2015.v3.n3.2.